We are live on ! Find out more

113 hedge funds and large institutions have $261M invested in Axogen in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

4% more capital invested

Capital invested by funds: $250M → $261M (+$10.3M)

0.78% more ownership

Funds ownership: 75.4%76.18% (+0.78%)

14% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 42

14% less funds holding

Funds holding: 132113 (-19)

52% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 29

Holders
113
Holders Change
-19
Holders Change %
-14.39%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
14
Increased
36
Reduced
42
Closed
29
Calls
$841K
Puts
Net Calls
+$841K
Net Calls Change
-$644K

AXGN Hedge Fund Activity: Q2 2022 in Review

113 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Axogen (AXGN) for Q2 2022, worth a combined $261M — up 4.1% from $250M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of AXGN and 14 opened new positions — a net loss of 15 holders — while 42 trimmed existing stakes and 36 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $17.8M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $3.22M.

  • 113 institutional investors held Axogen (AXGN) as of Q2 2022, down from 132 in Q1 2022.
  • Funds reported $261M of Axogen stock for Q2 2022, up 4.1% quarter-over-quarter.
  • 14 funds opened new Axogen positions in Q2 2022 and 29 closed out, a net change of -15 holders.
  • The largest Axogen buyer in Q2 2022 was Point72 Asset Management, an estimated $17.8M added.
  • The largest Axogen seller in Q2 2022 was Jacobs Levy Equity Management, an estimated $3.22M sold.

Based on aggregated 13F filings for Q2 2022.